TGM2 and breast carcinoma: In addition, we stained representative tissue sections (where TG2 is expressed in the stroma) with anti-phospho-FAK or anti-phospho-ERK antibodies to evaluate the effect of stromal TG2 on activation of integrin dependent downstream signaling in breast cancer tissues.